Stock VCEL VERICEL CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Vericel Corporation

Equities

VCEL

US92346J1088

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-27 EDT 		5-day change 1st Jan Change
46.91 USD +2.51% Intraday chart for Vericel Corporation +5.04% +31.73%
06-20 TD Cowen Initiates Vericel at Buy With $55 Price Target MT
06-14 Vericel Insider Sold Shares Worth $1,526,350, According to a Recent SEC Filing MT

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024
GL
Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024
GL
Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024
AQ
Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance
GL
Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024
GL
Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance
GL
Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance
AQ
Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024
GL
Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024
AQ
Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024
GL
Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024
AQ
Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
GL
Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results
GL
Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results
AQ
Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024
GL
MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid Development for the U.S. Army
AQ
Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
GL
Vericel to Present at the Stephens Annual Investment Conference
GL
Vericel to Report Third-Quarter 2023 Financial Results on November 8, 2023
GL
Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) Study of Thermal Burn Patients Treated with NexoBrid
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VCEL Stock
  4. News Vericel Corporation
  5. Press Releases